This is an interesting thread, and I guess somewhat timely for me.
I had surgery as my primary treatment back in May 2011. The post-up pathology was not exactly the best: Gleason downgraded to 6 (yeah for me!) but EPE could not be determined and I had a focal positive margin. Final staging was pT2cpN0. You can review my post-op pathology by clicking
here.
Since then, my PSA slowly rose until Feb 2014 after which I started taking Avodart in hopes of slowing the velocity of the PSA rise, though I was well aware that an eventual BCR was most likely. You can see my entire PSA history since surgery to today by clicking on the link in my signature below.
Fast forward to today. I just got back my quarterly PSA test and I am now up to .041.
A recent post on the forum suggested that for folks with an aggressive post-op pathology with an increasing PSA beyond .03, they should consider receiving SRT in hopes of arresting and possibly curing the cancer. That post is located
here.
So it seems I'm approaching a quandary: Do I treat now, do I treat later, or not at all?
With all the potential dangers surrounding SRT, how do I determine if and when to treat my G6 cancer, which I'm assuming may or may not be indolent? As David (Purgatory) alluded to earlier, is it necessary to treat something that may never lead to any harm on its own?